Ascendis Pharma (ASND)
(Real Time Quote from BATS)
$139.04 USD
-0.61 (-0.44%)
Updated Aug 15, 2024 10:04 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Ascendis Pharma A/S [ASND//]
Reports for Purchase
Showing records 121 - 140 ( 303 total )
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Skytrofa Sales In-Line with Survey Results, Launch Outlook;All Eyes on PTH
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Survey Highlights SKYTROFA''s Safety and Efficacy - Reveals Payer Headwinds
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Generating Value in 2022 with Key Catalysts in All Programs & SKYTROFA Launch
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Starting the New Year Off Right: TC-hGH Receives EU Approval for Pediatric GHD
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
R&D Day: Looking Ahead to More Pipeline Progress and Multiple Catalysts in ''22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
84-Wk TC-PTH Data Set Stage for Q1:22 Ph3 Readout; TC-hGH Positive CHMP Opinion
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Q3: Ascending to Greater Heights with SKYTROFA Launch & Pipeline Progress
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Sky''s the Limit - SKYTROFA U.S. Launch Underway; PT to $191
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Normalized and Stabilized BMD Z-Scores Bolster TC-PTH''s Efficacy Profile
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L